Form D · Biotechnology
Genapsys, Inc.
Redwood City, CA · CIK 0001572246
Offering snapshot reported Mar 4, 2021 · SEC filing
- Reported sold
- $28.5M Offering amount: $70M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 8, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2021 | Initial | $28,500,007 | No comparison | 2 | SEC filing |
| Jan 2, 2018 | Initial | $32,533,708 | No comparison | 2 | SEC filing |
| Nov 14, 2013 | Initial | $36,486,995 | No comparison | 7 | SEC filing |
| Mar 22, 2013 | Initial | $8,493,002 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $750K (estimated)
- Form D file number
- 021-391172
Source: Form D, filed Mar 4, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laurent Bellon | Executive |
| Xiangmin Cui | Director |
| Hesaam Esfandyarpour | Director |
| Hamid Moghadam | Director |
| Jason Myers | Executive |
| Fred Nazem | Director |
| Rakesh Sachdev | Director |
| Harish Soundararajanand | Director |
| Frank Witney | Director |
| Cui Xiangmin | Director |
| Robert Zollars | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Cardinal Way
Redwood City, CA, 94063
Redwood City, CA, 94063